Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) and Pharmacodynamics (PD) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer's Disease (AD)
Clinical trial NCT06673069 · TERMINATED
Trial details
- NCT number
- NCT06673069
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-20
- Primary completion
- 2025-12-03
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.